Embora seja bem estabelecido que a exposição a baixas temperaturas resulte em ativação simpática e hiperglicemia, os mecanismos moleculares envolvidos na regulação neural da produção hepática de glicose ainda não são bem conhecidos. Portanto, o objetivo do presente estudo foi investigar o papel da inervação simpática na regulação de genes e enzimas chaves da neoglicogênese hepática, em roedores expostos agudamente ao frio. Para isso, foram utilizados dois modelos experimentais de desnervação simpática: a simpatectomia química em camundongos induzida pelo tratamento com 6-hidroxidopamina (100 mg.kg-1.dia-1; 1º, 2º e 7º dia de vida pós-natal; i.p). e a desnervação local dos nervos hepáticos por fenol (95%) em ratos. A exposição de camundongos ao frio (4ºC), durante 1, 3 e/ou 6h, induziu hiperglicemia, hipotermia, depleção do conteúdo de glicogênio hepático e ativação da neoglicogênese, estimada pela elevada expressão gênica e atividade das enzimas glicose-6-fosfatase e fosfoenolpiruvato carboxiquinase (PEPCK). Em paralelo, verificou-se que a exposição ao frio induziu um drástico aumento na expressão do RNAm do Nr4a1 e do PGC1-?, dois genes-alvos de CREB que participam do complexo de ativação transcricional dos genes que codificam as enzimas neoglicogênicas estudadas. A simpatectomia não afetou a depleção dos estoques de glicogênio hepático induzida pelo frio, mas reduziu o aumento do conteúdo hepático de noradrenalina e AMPc e acentuou a hipotermia, bem como preveniu a hiperglicemia, sendo este efeito associado ao bloqueio da expressão gênica e atividade da glicose-6-fosfatase e da PEPCK e do RNAm do Nr4a1, em todos os tempos estudados. Resultados bastante semelhantes foram observados em ratos submetidos à lesão dos nervos hepáticos com fenol e expostos ao frio durante 24h. Tanto a adrenalectomia como a adrenodemedulação (remoção da medula da adrenal) não alteraram o efeito estimulatório do frio na atividade e expressão gênica das enzimas neoglicogênicas de camundongos. Porém, em ratos expostos ao frio, a adrenodemedulação bloqueou aIII hiperglicemia e reduziu parcialmente a hiperexpressão dos genes da glicose-6-fosfatase e PEPCK. Estes resultados mostram a importância fisiológica da inervação simpática do fígado de roedores na estimulação do programa gênico da neoglicogênese, durante o estresse térmico agudo. / Although it is well established that exposure to low temperatures leads to sympathetic activation and hyperglycemia, the molecular mechanisms related to the neural regulation of hepatic glucose production remain elusive. Therefore, the goal of the present study was to investigate the role of sympathetic innervation in the regulation of genes and key enzymes of hepatic gluconeogenesis in liver of rodents exposed to acute cold. For this, two experimental models of sympathetic denervation were used: the chemical sympathectomy in mice induced by 6-hydroxydopamine treatment (100 mg.kg-1.day-1; 1º, 2º and 7ºdays of neonatal life; i.p.) and local denervation of hepatic nerves by phenol (95%) in rats. Exposure of mice to cold (4° C) for 1, 3 and / or 6 h induced hyperglycemia, hypothermia, depletion of hepatic glycogen content and activation of gluconeogenesis, estimated by high gene expression and activity of the enzymes glucose-6-phosphatase and phosphoenolpyruvate carboxykinase (PEPCK). In parallel, it was found that exposure to cold induced a dramatic increase in Nr4a1 and PGC1-? mRNA expression, two CREB target genes that participate in the transcriptional activation complex of the genes encoding the gluconeogenesis enzymes studied. The sympathectomy did not affect the depletion of cold-induced hepatic glycogen stores but reduced the hepatic content of noradrenaline and cAMP and increased hypothermia, as well as prevented hyperglycemia, and this effect was associated with the blockade of gene expression and enzymatic activity of glucose-6-phosphatase and PEPCK and Nr4a1 mRNA levels, at all time intervals investigated. Similar results were observed in rats submitted to hepatic nerve damage with phenol and exposed to cold for 24h. Either adrenalectomy or adrenodemedullation (surgical removal of the adrenal medulla) did not alter the stimulatory effect of cold on the activity and gene expression of the gluconeogenesis enzymes of mice. However, in cold-exposed rats, adrenodemedullation blocked hyperglycemia and partially reduced overexpression of the glucose-6-phosphatase and PEPCK mRNA.V These results show the physiological role of the hepatic sympathetic innervation in the transcriptional program associated with gluconeogenesis, during acute thermal stress.

Embora seja bem estabelecido que a exposição a baixas temperaturas resulte em ativação simpática e hiperglicemia, os mecanismos moleculares envolvidos na regulação neural da produção hepática de glicose ainda não são bem conhecidos. Portanto, o objetivo do presente estudo foi investigar o papel da inervação simpática na regulação de genes e enzimas chaves da neoglicogênese hepática, em roedores expostos agudamente ao frio. Para isso, foram utilizados dois modelos experimentais de desnervação simpática: a simpatectomia química em camundongos induzida pelo tratamento com 6-hidroxidopamina (100 mg.kg-1.dia-1; 1º, 2º e 7º dia de vida pós-natal; i.p). e a desnervação local dos nervos hepáticos por fenol (95%) em ratos. A exposição de camundongos ao frio (4ºC), durante 1, 3 e/ou 6h, induziu hiperglicemia, hipotermia, depleção do conteúdo de glicogênio hepático e ativação da neoglicogênese, estimada pela elevada expressão gênica e atividade das enzimas glicose-6-fosfatase e fosfoenolpiruvato carboxiquinase (PEPCK). Em paralelo, verificou-se que a exposição ao frio induziu um drástico aumento na expressão do RNAm do Nr4a1 e do PGC1-?, dois genes-alvos de CREB que participam do complexo de ativação transcricional dos genes que codificam as enzimas neoglicogênicas estudadas. A simpatectomia não afetou a depleção dos estoques de glicogênio hepático induzida pelo frio, mas reduziu o aumento do conteúdo hepático de noradrenalina e AMPc e acentuou a hipotermia, bem como preveniu a hiperglicemia, sendo este efeito associado ao bloqueio da expressão gênica e atividade da glicose-6-fosfatase e da PEPCK e do RNAm do Nr4a1, em todos os tempos estudados. Resultados bastante semelhantes foram observados em ratos submetidos à lesão dos nervos hepáticos com fenol e expostos ao frio durante 24h. Tanto a adrenalectomia como a adrenodemedulação (remoção da medula da adrenal) não alteraram o efeito estimulatório do frio na atividade e expressão gênica das enzimas neoglicogênicas de camundongos. Porém, em ratos expostos ao frio, a adrenodemedulação bloqueou aIII hiperglicemia e reduziu parcialmente a hiperexpressão dos genes da glicose-6-fosfatase e PEPCK. Estes resultados mostram a importância fisiológica da inervação simpática do fígado de roedores na estimulação do programa gênico da neoglicogênese, durante o estresse térmico agudo. / Although it is well established that exposure to low temperatures leads to sympathetic activation and hyperglycemia, the molecular mechanisms related to the neural regulation of hepatic glucose production remain elusive. Therefore, the goal of the present study was to investigate the role of sympathetic innervation in the regulation of genes and key enzymes of hepatic gluconeogenesis in liver of rodents exposed to acute cold. For this, two experimental models of sympathetic denervation were used: the chemical sympathectomy in mice induced by 6-hydroxydopamine treatment (100 mg.kg-1.day-1; 1º, 2º and 7ºdays of neonatal life; i.p.) and local denervation of hepatic nerves by phenol (95%) in rats. Exposure of mice to cold (4° C) for 1, 3 and / or 6 h induced hyperglycemia, hypothermia, depletion of hepatic glycogen content and activation of gluconeogenesis, estimated by high gene expression and activity of the enzymes glucose-6-phosphatase and phosphoenolpyruvate carboxykinase (PEPCK). In parallel, it was found that exposure to cold induced a dramatic increase in Nr4a1 and PGC1-? mRNA expression, two CREB target genes that participate in the transcriptional activation complex of the genes encoding the gluconeogenesis enzymes studied. The sympathectomy did not affect the depletion of cold-induced hepatic glycogen stores but reduced the hepatic content of noradrenaline and cAMP and increased hypothermia, as well as prevented hyperglycemia, and this effect was associated with the blockade of gene expression and enzymatic activity of glucose-6-phosphatase and PEPCK and Nr4a1 mRNA levels, at all time intervals investigated. Similar results were observed in rats submitted to hepatic nerve damage with phenol and exposed to cold for 24h. Either adrenalectomy or adrenodemedullation (surgical removal of the adrenal medulla) did not alter the stimulatory effect of cold on the activity and gene expression of the gluconeogenesis enzymes of mice. However, in cold-exposed rats, adrenodemedullation blocked hyperglycemia and partially reduced overexpression of the glucose-6-phosphatase and PEPCK mRNA.V These results show the physiological role of the hepatic sympathetic innervation in the transcriptional program associated with gluconeogenesis, during acute thermal stress.

Knowledge on the precise effects of surplus glucose supply in dairy cows is limited by the lack of information on how intermediary metabolism adapts at different levels of glucose availability. Therefore, a gradual increase of glucose supply via intravenous glucose infusion was used in the present study to test the dose effect of surplus provision of glucose on the metabolic status and milk production of dairy cows. Furthermore, the effects of increasing levels of surplus glucose on mRNA expressions and activities of rate-limiting enzymes involved in hepatic gluconeogenesis were investigated. Based on a previous finding that a positive energy balance may decrease hepatic carnitine palmitoyltransferase (CPT) enzyme activity, it was also of interest whether skeletal muscle CPT activity is downregulated in a similar manner during positive energy balance. Twelve midlactating Holstein-Friesian dairy cows were continuously infused over a 28-d experimental period with either saline (SI group, six cows) or 40% glucose solutions (GI group, six cows). The infusion dose was calculated as a percentage of the daily energy (NEL) requirements by the animal, starting at 0% on d 0 and increasing gradually by 1.25%/d until a maximum dose of 30% was reached by d 24. Dose was then maintained at 30% NEL requirement for 5 d. No infusions were made between d 29-32. Liver and skeletal muscle biopsies were taken on d 0, 8, 16, 24, and 32. Body weight (BW) and back fat thickness (BFT) were recorded on biopsies days. Blood samples were taken every 2 d. In addition, blood samples over 24 h (6-h intervals) were taken the days before each biopsy. Milk and urine samples were taken on biopsies days. BW and BFT increased linearly with increasing glucose dose for GI cows. No differences were observed in the dry matter intake, milk energy output, and energy corrected milk yield between groups. However, milk protein percentage and yield increased linearly in the GI group. Only occasional increases in blood glucose and insulin concentrations were observed in blood samples taken at 1000 h every 2 d. However, during infusion dose of 30% NEL requirements on d 24, GI cows developed postprandial hyperglycemia associated with hyperinsulinemia, coinciding with glucosuria. The revised quantitative insulin sensitivity check index (RQUIKI) indicated linear development of insulin resistance for the GI treatment. GI decreased serum concentrations of beta-hydroxybutyrate (BHBA) and blood urea nitrogen and tended to decrease the serum concentration of non-esterified fatty acids (NEFA). Liver glycogen content increased, while glycogen content in skeletal muscle only tended to increase by GI. No significant changes were observed in the activities and relative mRNA expression levels of hepatic phosphoenolpyruvate carboxykinase and glucose 6-phospatase. The activity of fructose 1,6-bisphosphatase (FBPase) and relative mRNA expression levels of pyruvate carboxylase (PC) were decreased in the GI group but only during the high dose of glucose infusion. Hepatic CPT activity decreased with GI and remained decreased on d 32. The hepatic expression levels of CPT-1A and CPT-2 mRNA were not significantly altered but tended to reflect the changes in enzyme activity. No effect of glucose infusion was observed on skeletal muscle CPT activity. The aforementioned adaptations were reversed four days after the end of glucose infusions except for those of BW, BFT, and lipid metabolism (i.e. serum BHBA and NEFA concentrations, hepatic CPT activity). It is concluded that mid-lactation dairy cows on an energy-balanced diet direct intravenously infused glucose predominantly to body fat reserves but not to increased lactation performance. Cows rapidly adapted to increasing glucose supply but experienced dose-dependent development of insulin resistance corresponding with postprandial hyperglycemia/hyperinsulinemia and glucosuria at dosages equivalent to 30% NEL requirements. The catalytic capacity of key hepatic gluconeogenesis enzymes in mid-lactating dairy cows is not significantly affected by nutritionally relevant increases of glucose supply. Only very high dosages selectively suppress PC transcription and FBPase activity. Finally, it can be concluded that suppression of CPT activity by positive energy balance appears to be specific for the liver in midlactating dairy cows.

Knowledge on the precise effects of surplus glucose supply in dairy cows is limited by the lack of information on how intermediary metabolism adapts at different levels of glucose availability. Therefore, a gradual increase of glucose supply via intravenous glucose infusion was used in the present study to test the dose effect of surplus provision of glucose on the metabolic status and milk production of dairy cows. Furthermore, the effects of increasing levels of surplus glucose on mRNA expressions and activities of rate-limiting enzymes involved in hepatic gluconeogenesis were investigated. Based on a previous finding that a positive energy balance may decrease hepatic carnitine palmitoyltransferase (CPT) enzyme activity, it was also of interest whether skeletal muscle CPT activity is downregulated in a similar manner during positive energy balance. Twelve midlactating Holstein-Friesian dairy cows were continuously infused over a 28-d experimental period with either saline (SI group, six cows) or 40% glucose solutions (GI group, six cows). The infusion dose was calculated as a percentage of the daily energy (NEL) requirements by the animal, starting at 0% on d 0 and increasing gradually by 1.25%/d until a maximum dose of 30% was reached by d 24. Dose was then maintained at 30% NEL requirement for 5 d. No infusions were made between d 29-32. Liver and skeletal muscle biopsies were taken on d 0, 8, 16, 24, and 32. Body weight (BW) and back fat thickness (BFT) were recorded on biopsies days. Blood samples were taken every 2 d. In addition, blood samples over 24 h (6-h intervals) were taken the days before each biopsy. Milk and urine samples were taken on biopsies days. BW and BFT increased linearly with increasing glucose dose for GI cows. No differences were observed in the dry matter intake, milk energy output, and energy corrected milk yield between groups. However, milk protein percentage and yield increased linearly in the GI group. Only occasional increases in blood glucose and insulin concentrations were observed in blood samples taken at 1000 h every 2 d. However, during infusion dose of 30% NEL requirements on d 24, GI cows developed postprandial hyperglycemia associated with hyperinsulinemia, coinciding with glucosuria. The revised quantitative insulin sensitivity check index (RQUIKI) indicated linear development of insulin resistance for the GI treatment. GI decreased serum concentrations of beta-hydroxybutyrate (BHBA) and blood urea nitrogen and tended to decrease the serum concentration of non-esterified fatty acids (NEFA). Liver glycogen content increased, while glycogen content in skeletal muscle only tended to increase by GI. No significant changes were observed in the activities and relative mRNA expression levels of hepatic phosphoenolpyruvate carboxykinase and glucose 6-phospatase. The activity of fructose 1,6-bisphosphatase (FBPase) and relative mRNA expression levels of pyruvate carboxylase (PC) were decreased in the GI group but only during the high dose of glucose infusion. Hepatic CPT activity decreased with GI and remained decreased on d 32. The hepatic expression levels of CPT-1A and CPT-2 mRNA were not significantly altered but tended to reflect the changes in enzyme activity. No effect of glucose infusion was observed on skeletal muscle CPT activity. The aforementioned adaptations were reversed four days after the end of glucose infusions except for those of BW, BFT, and lipid metabolism (i.e. serum BHBA and NEFA concentrations, hepatic CPT activity). It is concluded that mid-lactation dairy cows on an energy-balanced diet direct intravenously infused glucose predominantly to body fat reserves but not to increased lactation performance. Cows rapidly adapted to increasing glucose supply but experienced dose-dependent development of insulin resistance corresponding with postprandial hyperglycemia/hyperinsulinemia and glucosuria at dosages equivalent to 30% NEL requirements. The catalytic capacity of key hepatic gluconeogenesis enzymes in mid-lactating dairy cows is not significantly affected by nutritionally relevant increases of glucose supply. Only very high dosages selectively suppress PC transcription and FBPase activity. Finally, it can be concluded that suppression of CPT activity by positive energy balance appears to be specific for the liver in midlactating dairy cows.